Home › Research › Tau biomarkers
Plasma microRNAs as potential biomarkers in early Alzheimer disease expression
Peña-Bautista C, Tarazona-Sánchez A, Braza-Boils A, Balaguer A, Ferré-González L, Cañada-Martínez AJ, Baquero M, Cháfer-Pericás C.. Scientific reports, 2022-09-16
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
The microRNAs (miRNAs) are potential biomarkers for complex pathologies due to their involvement in the regulation of several pathways. Alzheimer Disease (AD) requires new biomarkers in minimally invasive samples that allow an early diagnosis. The aim of this work is to study miRNAS as potential AD biomarkers and their role in the pathology development.
What this study adds
Evidence grade: Low
The record lists 46 participants. This small study of 46 people looked at whether microRNAs in blood could serve as less invasive biomarkers for early Alzheimer disease. It is preliminary and does not test any treatment, so it cannot yet say whether these markers help patients.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Peña-Bautista, C., Tarazona-Sánchez, A., Braza-Boils, A., Balaguer, A., Ferré-González, L., Cañada-Martínez, A. J., et al. (2022). Plasma microRNAs as potential biomarkers in early Alzheimer disease expression. Scientific reports. https://doi.org/10.1038/s41598-022-19862-6
Vancouver
Peña-Bautista C, Tarazona-Sánchez A, Braza-Boils A, Balaguer A, Ferré-González L, Cañada-Martínez AJ, et al. Plasma microRNAs as potential biomarkers in early Alzheimer disease expression. Scientific reports. 2022. doi:10.1038/s41598-022-19862-6. PMID: 36114255.
BibTeX
@article{penabautista2022-36114255,
author = {Peña-Bautista, C. and Tarazona-Sánchez, A. and Braza-Boils, A. and Balaguer, A. and Ferré-González, L. and Cañada-Martínez, A. J. and Baquero, M. and Cháfer-Pericás, C.},
title = {{Plasma microRNAs as potential biomarkers in early Alzheimer disease expression}},
journal = {Scientific reports},
year = {2022},
doi = {10.1038/s41598-022-19862-6},
pmid = {36114255},
url = {https://doi.org/10.1038/s41598-022-19862-6}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Alzheimer Disease (AD) requires new biomarkers in minimally invasive samples that allow an early diagnosis.
- The aim of this work is to study miRNAS as potential AD biomarkers and their role in the pathology development.
- In this study, participants (n = 46) were classified into mild cognitive impairment due to AD (MCI-AD, n = 19), preclinical AD (n = 8) and healthy elderly controls (n = 19), according to CSF biomarkers levels (amyloid β42, total tau, phosphorylated tau) and neuropsychological assessment.
- Then, plasma miRNAomic expression profiles were analysed by Next Generation Sequencing.
Why it matters
This small study of 46 people looked at whether microRNAs in blood could serve as less invasive biomarkers for early Alzheimer disease. It is preliminary and does not test any treatment, so it cannot yet say whether these markers help patients.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants46
- Evidence strengthLow
How this study scored 48/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Scientific reports) |
| Journal's citation record | 3 / 4 | Scientific Reports: journal h-index 463 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2022 — within 6 year(s) of the newest study here |
| Sample size | 1 / 4 | 46 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 50 times (OpenAlex, 2026-10-10) |
| Citations per year | 3 / 5 | 8.3 citations a year over 6 year(s) since 2022 |
| Impact for its field and year | 3 / 6 | Cited 3.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 2 other studies in this library |
| Still being cited | 2 / 4 | Cited 40 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Consuelo Cháfer‐Pericás: h-index 33 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Hospital Universitari i Politècnic La Fe: institution h-index 376 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 36114255) |
| Free to read | 2 / 2 | Free to read |
| Total | 48 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1038/s41598-022-19862-6
- PubMed: 36114255
- Original source →
- Free full text: Scientific Reports →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
2 studies in the alzhub library list this one in their references.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.